Gujarat Kidney & Super Speciality has debuted at Rs 120.75 on the BSE, up by 6.75 points or 5.92% from its issue price of Rs 114.00.
The scrip is currently trading at Rs. 115.40, up by 1.4 points or 1.23% from its issue price.
It has touched a high and low of Rs. 123.25 and Rs. 114.00 respectively. So far 11.22 lakh shares were traded on the counter.
The offering, which was open for subscription between December 22, 2025 and December 24, 2025 was subscribed 5.21 times. The issue price was fixed at Rs 114.00 per share i.e. at upper end of price band of Rs 108-114 apiece.
Gujarat Kidney and Super Speciality is one of the regional healthcare companies located in the central region of state of Gujarat and operate a chain of mid-sized multispeciality hospitals, providing integrated healthcare services, with a focus on secondary and tertiary care.
| Company Name | CMP |
|---|---|
| Apollo Hospital Ent. | 7514.70 |
| Max Healthcare Inst | 954.00 |
| Narayana Hrudayalay | 1754.55 |
| Aster DM Healthcare | 681.20 |
| Global Health | 1065.20 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: